Biotech entity
pharma is the sole category represented across all 1 tracked stories. Artificial Intelligence is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. We currently track 1 Biotech story that mention Tianjin Beichen Beimen Hospital, all published on March 9, 2026.
Last mentioned: Mar 9, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
pharma is the sole category represented across all 1 tracked stories. Artificial Intelligence is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. We currently track 1 Biotech story that mention Tianjin Beichen Beimen Hospital, all published on March 9, 2026. Each carries 2 original sources on average.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 17 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Tianjin Beichen Beimen Hospital. Shared-story counts are live from our verified record — not editorial picks.
Traditional Chinese Medicine (TCM) is undergoing a digital transformation, utilizing AI-assisted acupuncture and digital pulse diagnosis to standardize ancient practices. Supported by China's 'Healthy China 2030' initiative and the 15th Five-Year Plan, these technological advancements aim to provide scientific evidence and global scalability for TCM across 196 countries.
Tianjin Beichen Beimen Hospital is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
